Immune checkpoint inhibitors such as programmed cell death protein-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTL 4) have been associated with myocarditis, pericardial disease, arrythmias, heart failure, and acute myocardial infarction38–42. Here, CTLA4 is linked to myocarditis.